Technical Analysis for CRSP - CRISPR Therapeutics AG
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Earnings Movers | Other | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Up 4 Days in a Row | Strength | 0.00% | |
20 DMA Resistance | Bearish | 2.09% | |
Gapped Up | Strength | 2.09% | |
Up 3 Days in a Row | Strength | 2.09% | |
Oversold Stochastic | Weakness | 2.09% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 13 hours ago |
Possible Inside Day | about 13 hours ago |
20 DMA Resistance | about 17 hours ago |
Rose Above 20 DMA | about 17 hours ago |
Up 2% | about 17 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/06/2024
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine DNA CRISPR Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine DNA CRISPR Genome Editing Cas9
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 91.1 |
52 Week Low | 37.55 |
Average Volume | 1,405,667 |
200-Day Moving Average | 59.38 |
50-Day Moving Average | 67.52 |
20-Day Moving Average | 56.95 |
10-Day Moving Average | 54.94 |
Average True Range | 2.59 |
RSI (14) | 42.86 |
ADX | 29.0 |
+DI | 22.07 |
-DI | 24.40 |
Chandelier Exit (Long, 3 ATRs) | 57.47 |
Chandelier Exit (Short, 3 ATRs) | 60.50 |
Upper Bollinger Bands | 63.41 |
Lower Bollinger Band | 50.49 |
Percent B (%b) | 0.51 |
BandWidth | 22.68 |
MACD Line | -3.23 |
MACD Signal Line | -3.89 |
MACD Histogram | 0.6637 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 59.47 | ||||
Resistance 3 (R3) | 59.32 | 58.37 | 59.07 | ||
Resistance 2 (R2) | 58.37 | 57.76 | 58.45 | 58.94 | |
Resistance 1 (R1) | 57.72 | 57.38 | 58.05 | 57.86 | 58.80 |
Pivot Point | 56.77 | 56.77 | 56.93 | 56.84 | 56.77 |
Support 1 (S1) | 56.11 | 56.15 | 56.44 | 56.26 | 55.32 |
Support 2 (S2) | 55.16 | 55.77 | 55.23 | 55.18 | |
Support 3 (S3) | 54.50 | 55.16 | 55.05 | ||
Support 4 (S4) | 54.65 |